Cita APA

Robb, C. M., Kour, S., Contreras, J. I., Agarwal, E., Barger, C. J., Rana, S., . . . Natarajan, A. (2017). Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget.

Chicago Style Citation

Robb, Caroline M., et al. "Characterization of CDK(5) Inhibitor, 20-223 (aka CP668863) for Colorectal Cancer Therapy." Oncotarget 2017.

Cita MLA

Robb, Caroline M., et al. "Characterization of CDK(5) Inhibitor, 20-223 (aka CP668863) for Colorectal Cancer Therapy." Oncotarget 2017.